Anti-inflammatory Sesquiterpene-quinones from the New Zealand Sponge Dysidea cf. cristagalli
- 5 August 2005
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 68 (9) , 1431-1433
Abstract
The inhibition of superoxide production by human neutrophils has been used to screen New Zealand's unique biota for anti-inflammatory natural products. Bioactivity-directed isolation on an extract of the sponge Dysidea cf. cristagalli led to a new sesquiterpene-quinone (4) with anti-inflammatory activity, plus acetylated hydroquinone (3). These compounds inhibited superoxide production in vitro with IC50's of 3 μM (3) and 11 μM (4).Keywords
This publication has 12 references indexed in Scilit:
- Merosesquiterpenes from Two Sponges of the Genus DysideaJournal of Natural Products, 2005
- Anti-inflammatory metabolites from marine spongesChemical Society Reviews, 2005
- Marine natural productsNatural Product Reports, 2005
- New therapies for chronic obstructive pulmonary diseaseExpert Opinion on Investigational Drugs, 2004
- Osteoarthritis therapy--are there still unmet needs?Rheumatology, 2004
- Cyclooxygenase-2: A Therapeutic TargetAnnual Review of Medicine, 2002
- Avarol and Related Compounds from the New Zealand Marine Sponge Dysidea sp.Australian Journal of Chemistry, 1997
- Evidence that cell survival is controlled by interleukin‐3 independently of cell proliferationJournal of Cellular Physiology, 1995
- Defensive Secretion of the Millipede Floridobolus penneriJournal of Natural Products, 1993
- New Avarone and Avarol Derivatives from the Marine Sponge Dysidea cinereaJournal of Natural Products, 1991